FDAnews Device Daily Bulletin

CRYOCOR REPORTS FIRST QUARTER 2006 RESULTS

May 5, 2006
A A

CryoCor, Inc. CRYO, a medical device company focused on the treatment of cardiac arrhythmias, today reported on its financial results for the three months ended March 31, 2006 and provided an update on its ongoing clinical initiatives. CryoCor continues to analyze the results of the pivotal trial for atrial flutter, or AFL, to determine whether to amend its application for pre-market approval, or PMA, for the treatment of AFL.
MSN Money